Gene Query: CBSL

Dataset Description Geneva Score
Functional Haploid Human Oocytes Generated from Polar Body Genomes 551.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 551.06
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 350.43
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 218.67
RNA-sequencing of human liver tissue 134.39
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 124.68
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 122.35
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 107.47
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 101.91
Evaluating pre-clinical models for studying NASH driven HCC. 100.78
Biological effect of chronic mistranslation in mammalian cells 93.01
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 88.03
RNA-seq in transgenic cells 73.26
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 65.97
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 57.1
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 53.03
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 48.7
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 48.03
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 46.26
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 45.81
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 44.75
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 44.06
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 43.62
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 43.44
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 41.54
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 41.08
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 40.77
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 40.38
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 40.29
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 39.27
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 38.59
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 38.32
Differentially expressed vascular development genes for iPSC-ECs from CDI 37.74
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 37.65
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 37.65
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 37.12
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 37.12
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 36.94
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 36.94
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 36.26
NHLRC1 re-expression in cancer cells 35.56
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 35.25
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 35.23
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 35.02
Transcriptome analysis of H9 hESC derived cerebral organoids 33.85
Effect of disulfiram treatment on pediatric high grade glioma 33.38
Regulation of Lipids is Central to Replicative Senescence 33.29
RNA-seq analysis of uveal melanoma cells treated with FR900359 33.22
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 32.69
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 32.65
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 32.6
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 32.6
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 32.5
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 32.31
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 32.18
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 32.14
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 31.9
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 31.9
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 31.5
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 30.94
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 30.9
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 29.97
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 29.6
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 29.44
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 29.44
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 29.12
The effect of insulin on mRNA transcription of human pluripotent stem cells 29.11
RNA-seq of human fibroblasts after irradiation 28.22
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 28.18
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 27.63
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 27.12
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 27.12
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 27.02
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 26.17
The landscape of alternative splicing in aggressive prostate cancers 25.95
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 25.44
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 25.44
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 24.74
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 23.6
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 23.15
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 22.61
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 22.38
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 22.38
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 22.37
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 21.88
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 21.79
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 21.61
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 21.47
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 21.44
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 21.09
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 21.04
Patient-derived luminal breast cancer xenografts with progestins 21.04
Alagille_Nodder 20.81
RNA Seq of Alagille liver biopsies 20.81
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 20.75
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 20.68
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 20.64
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 20.48
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 20.41
Transcriptome analysis upon C6orf203 silencing 20.2
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 20.11
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 20.0
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 19.96
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 19.93
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 19.9
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 19.88
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 19.54
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 19.45
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 19.43
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 19.37
RNA-seq of naive and primed ES cells (NHSM) 19.31
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 18.92
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 18.88
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 18.72
EP400 is required for Max and MCPyV mediated gene activation 18.71
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 18.63
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 18.04
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 17.8
17.67
Accurate annotation of human protein-coding small open reading frames 17.59
Studying the selectivity of a small molecule Synucleozid on transcriptome 17.51
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 17.42
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 17.35
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 17.33
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 17.3
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 17.24
Ectoderm specification of H1 human embryonic stem cells 17.23
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 17.22
MEIS1 regulates hematopoiesis in hPSCs 17.12
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 17.09
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 17.03
Chromatin landscape of human visceral and subcutaneous adipocytes 17.02
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 17.01
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 16.95
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 16.82
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 16.82
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 16.82
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 16.8
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 16.7
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 16.61
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 16.56
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 16.46
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 16.24
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 16.23
Next Generation Sequencing of human SMA and healthy control Motor Neurons 16.14
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 16.13
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 16.03
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 15.88
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 15.63
High level DNA repair gene expression in human ES cells 15.54
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 15.53
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 15.34
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 15.29
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 15.29
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 15.13
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 14.81
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 14.81
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 14.61
Identification of global regulators of T-helper cell lineage specification 14.61
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 14.59
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 14.38
CDK4/6 inhibitor resistance in prostate cancer 14.31
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 14.27
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 14.07
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 14.07
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 14.06
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 14.03
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 14.02
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 13.89
RNA-seq of tumor cells following angiopellosis extravasation 13.84
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 13.8
Role of XRN2 ribonucleolytic activity in RNA metabolism 13.78
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 13.76
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 13.76
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 13.76
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 13.75
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 13.7
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 13.55
Glioblastoma stem cells infected by ZIKA virus 13.53
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 13.52
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 13.52
Random mono-allelic expression in MECP2-mutated cells 13.45
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 13.41
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.23
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 13.06
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 12.84
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 12.82
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 12.77
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 12.77
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 12.76
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.71
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.71
Tracking of dCas9-methyltransferase footprints 12.71
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 12.7
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 12.61
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 12.59
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 12.55
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 12.52
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 12.52
A transcriptome-wide divergence in protein translation scales with LIN28B expression 12.52
High-throughput sequencing of pluripotent cells 12.5
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 12.49
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 12.32
Global analysis of alternative splicing regulated by RBM10 12.11
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 12.1
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 12.1
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 11.96
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 11.95
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 11.89
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 11.76
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 11.75
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 11.75
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 11.71
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 11.65
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 11.65
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 11.62
IRF1 regulates IFN dependent and independent gene expression 11.54
Epigenome regulation during epidermal lineage commitment [RNA-seq] 11.37
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 11.35
Downregulation of DDX5/DDX17 and REST 11.29
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 11.28
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 11.22
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 11.12
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 11.12
The effect of Abl kinases on non-small cell carcinoma global transcriptome 11.01
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 10.85
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 10.83
Global epigenomic reconfiguration during mammalian brain development 10.75
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 10.58
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 10.53
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 10.41
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 10.39
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 10.35
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 10.24
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 10.06
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 10.06
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 10.06
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 10.05
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 10.05
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 10.02
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 10.0
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 9.9
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 9.87
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 9.85
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 9.83
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 9.81
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 9.71
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 9.57
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.56
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.56
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 9.56
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 9.55
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 9.55
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 9.53
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.5
Developmental stage specific chromosome architecture in human erythroid cells 9.5
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 9.48
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 9.47
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 9.46
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 9.46
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 9.3
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 9.3
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 9.21
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 9.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 9.2
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 9.11
iPSC-Derived Cholangiocytes 9.07
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 9.06
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 9.02
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 8.99
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 8.98
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 8.71
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 8.57
RNA transcriptome analysis during HSV-1 infection 8.57
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 8.37
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 8.37
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 8.28
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 8.26
Gene expression regulated by CSA and CSB in neuroblastoma cell line 8.17
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 8.14
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 8.14
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 8.13
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 8.13
Functional role of CPPED1 in trophoblasts. 8.12
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 8.03
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 7.98
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 7.95
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 7.92
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 7.86
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 7.84
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 7.82
HEK293 TFAM Knockout Expression Study 7.64
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 7.63
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 7.61
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.61
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.61
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 7.57
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 7.57
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 7.52
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 7.52
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 7.51
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 7.38
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 7.37
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 7.34
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 7.3
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.18
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 7.08
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 7.08
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.02
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 7.0
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 7.0
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.92
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 6.76
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 6.71
RNA-seq of cancer cell lines treated with T-025 6.63
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 6.63
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 6.6
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 6.58
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 6.58
Human optic chiasm from healthy controls and multiple sclerosis patients 6.47
Multiple sclerosis and EAE 6.47
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 6.27
Differential gene expression in Jagged1 treated human dental pulp cells. 6.25
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 6.25
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 6.22
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.17
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  6.16
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.11
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 6.06
scRNASeq analysis of cycling cardiomyocytes 6.02
U2AF1 mutations alter splice site recognition in hematological malignancies 5.98
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.91
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 5.89
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 5.87
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 5.86
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.84
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 5.81
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.76
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.7
FGF2 regulation of gene expression in stable inducible Neurons 5.59
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.44
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 5.2
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 5.17
Epigenomic conservation of transposable element silencing 5.09
Epigenomic conservation of transposable element silencing [RNA-seq] 5.09
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.07
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.07
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.02
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 5.01
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.93
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 4.77
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 4.77
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 4.76
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 4.76
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.74
Metabolism as an early predictor of DPSCs aging 4.67
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 4.64
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 4.63
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 4.62
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.61
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 4.6
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.57
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.51
RNA seq analysis of human Fetal and adult derived Enterospheres 4.47
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.4
Disruption of GRIN2B impairs differentiation in human neurons 4.34
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 4.31
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.28
AMPK signaling for naïve pluripotency 4.26
AMPK signaling for naïve pluripotency [Hs] 4.26
KSDM1b Role in Ewing Sarcoma 4.23
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.23
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.23
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 4.2
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 4.18
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.14
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 4.11
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 4.09
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 4.07
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.0
hESC neural differentiation 3.98
RNA-seq analysis of gene expression patterns during hESC neural differentiation 3.98
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 3.97
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.89
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 3.82
Global transcriptome analysis of WT versus HEB-/- hESCs 3.69
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 3.68
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.66
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.65
RNA-Seq of the corpus callosum from 12 individuals 3.62
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.62
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.55
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.51
LIN28A Over-expression RNAseq 3.51
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.45
Epigenome regulation during epidermal lineage commitment 3.36
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 3.34
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.33
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 3.24
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.23
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.21
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 3.19
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.15
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.14
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.13
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.09
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 3.01
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 3.01
Determination of tRNA aminoacylation levels by high throughput sequencing 2.99
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.89
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.89
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.77
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.76
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.73
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.71
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 2.69
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 2.66
Comparative Analysis of Cas9 Activators Across Multiple Species 2.66
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 2.58
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.47
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.47
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.43
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.41
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 2.37
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.36
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.33
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 2.31
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.25
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.23
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.22
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.07
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.04
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.0
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.98
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.87
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 1.85
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.78
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.73
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.65
The DPYSL2 gene connects mTOR and schizophrenia 1.54
Hepatic transcriptome of pediatric hepatoblastoma. 1.52
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.51
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 1.49
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 1.49
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.46
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 1.46
Human islets of varying quality: the good, the (not so) bad and the ugly 1.32
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.3
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.28
RNA-seq of naive and primed ES cells 1.28
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.24
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.07
Molecular Criteria for Defining the Naive Human Pluripotent State 1.02
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.02
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.02
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.99
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.81
HEK293 Heat-shock experiment 0.81
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.8
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.8
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.75
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.7
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.68
BMS-470539 on human synovial fibroblasts 0.68
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.66
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.6
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.6
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.59
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.59
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.59
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.59
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.58
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.57
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.51
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.51
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.46
Generation and functional characterization of MDSC-like cells 0.46
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.4
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.4
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.4
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 0.38
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.37
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.23
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.23
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.21
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.19
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.19
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.18
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 0.18
Human ovarian granulosa cell transcriptome 0.17
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.17
Gene expression of thyroid cancer cell lines 0.11
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.1
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.09
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.09
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.08
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.08
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.08
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.06
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation